CME Group to Sue CFTC Over Perpetual Futures Approval
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: CNBC
- Litigation Announcement: CME Group CEO Terrence Duffy stated that the exchange will file a lawsuit against the Commodity Futures Trading Commission (CFTC) on Thursday, opposing the approval of perpetual futures contracts, which he argues should be classified as swaps under the Dodd-Frank Act, potentially impacting CME's market dominance.
- Market Impact Analysis: The CFTC's approval of Kalshi's bitcoin perpetual futures in May marks the first entry of this popular overseas asset class into the U.S. market, which could directly affect CME's trading volumes and market share, especially amid the growing interest in cryptocurrency trading.
- Strategic Preparation: Duffy noted that he has been preparing this lawsuit with the board for the past eight months, emphasizing that CME holds exclusive licenses with all benchmark providers, meaning all related trades must go through CME, which could further solidify its market position.
- Regulatory Response: CFTC Chair Michael Selig defended the approval of perpetual futures on CNBC, stating that it is essential to ensure regulated futures contracts are available in the U.S. market, indicating that tensions between the regulatory body and CME may escalate.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CME?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CME
Wall Street analysts forecast CME stock price to rise
10 Analyst Rating
4 Buy
4 Hold
2 Sell
Hold
Current: 261.600
Low
209.00
Averages
285.90
High
320.00
Current: 261.600
Low
209.00
Averages
285.90
High
320.00
About CME
CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Regulatory Support: CFTC Chair Michael Selig emphasized on CNBC that approving futures contracts with no expiration date is crucial for ensuring the safety of U.S. markets, aiming to bring internationally developed products onshore under strict regulations.
- Strong Market Demand: Following the launch of bitcoin perpetual futures, Kalshi reported over $3 billion in notional volume within just a week, indicating robust market demand for this innovative contract type, which could lead to further financial product innovations.
- Leverage Risk Discussion: Despite concerns from CME Group CEO regarding the high leverage risks associated with perpetual futures, Selig argued that proper disclosures and broker evaluations will ensure trading safety, countering the notion of excessive regulatory paternalism.
- Political Pressure Denial: Selig firmly denied that the CFTC's approval of perpetual futures was influenced by political pressure from the Trump administration, asserting that such insinuations are baseless and highlighting the independence and professionalism of regulatory decisions.
See More
- Litigation Announcement: CME Group CEO Terrence Duffy stated that the exchange will file a lawsuit against the Commodity Futures Trading Commission (CFTC) on Thursday, opposing the approval of perpetual futures contracts, which he argues should be classified as swaps under the Dodd-Frank Act, potentially impacting CME's market dominance.
- Market Impact Analysis: The CFTC's approval of Kalshi's bitcoin perpetual futures in May marks the first entry of this popular overseas asset class into the U.S. market, which could directly affect CME's trading volumes and market share, especially amid the growing interest in cryptocurrency trading.
- Strategic Preparation: Duffy noted that he has been preparing this lawsuit with the board for the past eight months, emphasizing that CME holds exclusive licenses with all benchmark providers, meaning all related trades must go through CME, which could further solidify its market position.
- Regulatory Response: CFTC Chair Michael Selig defended the approval of perpetual futures on CNBC, stating that it is essential to ensure regulated futures contracts are available in the U.S. market, indicating that tensions between the regulatory body and CME may escalate.
See More
- CEO Resignation Announcement: CME Group's CEO Terry Duffy announced plans to step down next year, marking the end of his decade-long leadership, which may impact the company's future strategic direction and market confidence.
- Lawsuit Against CFTC: Duffy stated that CME will sue the Commodity Futures Trading Commission on Thursday over its approval of perpetual futures, a move that could spark legal disputes within the industry and affect regulatory policies.
- Negative Market Reaction: Following the CFTC's approval of perpetual futures, shares of CME Group, Cboe, and ICE fell, as investors expressed concerns that this decision could pose a long-term competitive threat to existing exchanges, reflecting market caution towards new products.
- New CEO Appointment: CME announced Lynne Fitzpatrick as its first female CEO, succeeding Duffy, indicating potential significant changes in company culture and strategy as the new leadership takes over.
See More
- Strong Economic Data: US May retail sales rose 0.9% month-over-month, exceeding expectations of 0.6%, indicating resilient consumer demand that could positively impact future spending and economic recovery.
- Housing Market Recovery: Pending home sales in May increased by 3.8% month-over-month, significantly surpassing the expected 0.9%, marking the largest gain in 20 months, suggesting a rebound in the real estate market that may stimulate growth in related sectors.
- Oil Price Volatility: The agreement between the US and Iran to reopen the Strait of Hormuz has driven crude oil prices down to a 3.5-month low, increasing risk-on sentiment in the market, which may lead investors to reassess the risks and returns of energy-related assets.
- FOMC Meeting Focus: The market anticipates that the Federal Reserve will keep interest rates unchanged, but the press conference by new Chair Kevin Warsh will be pivotal, as investors closely watch his outlook on inflation to guide future investment decisions.
See More
- Strong Market Performance: The S&P 500 index rose by 0.23%, the Dow Jones Industrial Average increased by 0.26%, and the Nasdaq 100 climbed by 0.74%, reflecting market confidence in economic recovery, particularly driven by strong performances from chipmakers.
- Retail Sales Exceed Expectations: U.S. May retail sales increased by 0.9% month-over-month, surpassing the expected 0.6%, indicating resilient consumer demand that could further stimulate economic growth and influence future monetary policy.
- Oil Price Decline Affects Market Sentiment: The agreement between the U.S. and Iran to reopen the Strait of Hormuz has led to crude oil prices dropping to a 3.5-month low, enhancing risk-on sentiment in the markets and contributing to stock gains.
- FOMC Meeting in Focus: Market participants are closely watching the outcome of the FOMC meeting, where interest rates are expected to remain unchanged, but the guidance from new Chair Kevin Warsh will significantly impact market sentiment.
See More
- Leadership Change: CME Group announced that CEO Terry Duffy will step down on March 1, transitioning to the role of executive chairman, indicating a significant shift in the company's upper management that could impact future strategic directions.
- Transition Plan: Duffy's move to executive chairman means he will continue to play a crucial role within the company, ensuring a smooth management transition and maintaining operational continuity.
- Market Reaction: This news may affect investor sentiment, although no significant stock price fluctuations have been observed yet; leadership changes typically prompt market scrutiny regarding the company's future trajectory.
- Strategic Implications: Duffy's departure may signal deeper strategic adjustments within CME Group to adapt to the evolving market landscape and changing customer demands.
See More










